We show that the amber termination codon UAG can initiate protein synthesis in Escherichua coli. We mutated the initiation codon AUG of the chloramphenicol acetyltransferase (CAT) gene to UAG (CATaml) and translated mRNA derived from the mutant CAT gene in E. coli S-30 extracts. A full-length CAT polypeptide was synthesized in the presence of tRNAt 9 , a mutant E. coli initiator tRNA which has a change in the anticodon sequence from CAU to CUA. Addition of purified E. coli glutaminyl-tRNA synthetase substantially stimulated synthesis of the CAT polypeptide. Thus, initiation of protein synthesis with UAG and tRNAfVet most likely occurs with glutamine and not methionine. The UAG codon also initiates protein synthesis in vivo. To eliminate a weak secondary site of initiation from AUC, the fifth codon, we further mutagenized the CATaml gene at codons 2 (GAG GAC) and 5 (AUC ACC). Transformation ofE. coli with the resultant CATami.2.5 gene yielded transformants that synthesized CAT polypeptide and were resistant to chloramphenicol only when they were also transformed with the mutant tRNAwuYA gene. Immunoblot analyses and assays for CAT enzyme activity in extracts from transformed cells indicate that initiation from UAG is efficient, 60-70% of that obtained from AUG. Initiation of protein synthesis from UAG using a mutant initiator tRNA allows tightly regulated expression of specific genes. This may be generally useful for overproduction in E. coli and other eubacteria of proteins which are toxic to these cells.
enzyme activity in extracts from transformed cells indicate that initiation from UAG is efficient, 60-70% of that obtained from AUG. Initiation of protein synthesis from UAG using a mutant initiator tRNA allows tightly regulated expression of specific genes. This may be generally useful for overproduction in E. coli and other eubacteria of proteins which are toxic to these cells.
Initiation of protein synthesis in vivo always uses the amino acid methionine or its derivative formylmethionine in eubacteria, mitochondria, and chloroplasts (1) . The codon used for initiation, AUG, is also universal, although occasionally initiation by codons closely related to AUG and differing from it at one position such as UUG, GUG, CUG, AUA, ACG, AGG has been observed (1) (2) (3) (4) . However, the amino acid used for initiation is invariably methionine. The universal use of methionine as the initiating amino acid and of AUG as the initiating codon raises the question of whether protein synthesis in vivo can ever be initiated with an amino acid other than methionine and with a codon or codons that are not closely related to AUG.
By using Escherichia coli initiator tRNA misaminoacylated with valine or phenylalanine and then formylated, it has been shown in vitro that initiator tRNAs carrying these amino acids bind to the P (peptidyl-tRNA) site on E. coli ribosomes (5) . Also, by using synthetic mRNAs such as poly(U) and poly-(U,G) it has been shown that even noninitiator tRNAs such as Ac-Phe-tRNA and Ac-Trp-tRNA can initiate protein synthesis in E. coli extracts (6, 7) . The relationship of these in vitro studies to the situation in vivo is, however, not known. There is no evidence in E. coli or any organism for initiation of protein synthesis with an amino acid other than methionine or with a codon that is not closely related to AUG. In eukaryotic systems it appears that protein synthesis may be initiated only with methionine. A yeast initiator tRNA aminoacylated with methionine is active in initiation in vitro, whereas the same tRNA aminoacylated with isoleucine is not (8) .
During structure-function relationship studies of E. coli initiator tRNA (9-11) we generated a tRNA mutant in which the anticodon sequence CAU was changed to CUA. This mutant has the potential to read the amber termination codon UAG. Despite the fact that the mutant tRNA is aminoacylated with glutamine instead of methionine (11, 12) , the aminoacylated mutant tRNA is formylated by E. coli methionyl-tRNA transformylase (B. L. Seong and U.L.R., unpublished observations) and it has features known to be important for directing it to the E. coli ribosomal P site (9) . We have, therefore, used this mutant tRNA to ask whether protein synthesis can be initiated with UAG. Using chloramphenicolacetyl transferase (CAT) genes in which the initiator AUG codon has been changed to UAG, we show that UAG can initiate protein synthesis both in vitro and in vivo in E.
coli. Initiation with UAG requires the presence of the mutant tRNA and appears surprisingly efficient in vivo.
MATERIALS AND METHODS tRNA. The tRNA mutant used in this work and its isolation has been described previously (9) (10) (11) .
Mutagenesis of CAT Genes. CATam] mutant was generated by Baik L. Seong (Massachusetts Institute of Technology), using the gapped duplex method of mutagenesis as described before (13) . CAT2.5 and CATaml.2.5 were generated by phosphorothioate-based oligonucleotide mutagenesis (14) using a kit from Amersham. Efficiency of mutagenesis was greater than 90%. All mutants were characterized by sequence analysis.
Subcloning. Standard cloning techniques were used (15) and all clones/plasmid constructs were confirmed by sequence analysis. The vectors used for subcloning of the CAT, tRNA, and glutaminyl-tRNA synthetase (GlnRS) genes were based on pSP64 (16), pRSV (13), or pACYC (17) . Plasmid pAC1 was generated by deletion of the T7 RNA polymerase gene from pACT7 obtained from S. Karnik (Massachusetts Institute of Technology).
In Vitro Translations. S-30 extracts were prepared from E. coli MRE600 (18) and used as described previously (9) . The incubation mixture (12.5 (20) . Total proteins (15 or 30 Ag) were separated on SDS/15% polyacrylamide gels and electroblotted to polyvinylidine difluoride (PVDF) membranes (Millipore). CAT or f-lactamase was probed for with rabbit anti-CAT or anti-,f-lactamase antibodies (obtained from 5 Prime -> 3 Prime, Inc.) and detected with alkaline phosphatase-conjugated antibody to rabbit IgG (Promega) as the second antibody, using protocols provided by Millipore. shows the E. coli initiator tRNA mutant used in these studies. The mutant tRNA has a change in the anticodon from CAU to CUA. It can be aminoacylated with glutamine instead of methionine, although it is a poorer substrate for E. coli GlnRS compared to tRNAGin (11, 12) . The mutant tRNA has the potential to read the amber termination codon UAG. CATaml. An -24-kDa polypeptide, which corresponds to the size expected for CAT, is the predominant translation product of CAT mRNA (lane 2). As expected, this polypeptide is not present in translation products directed by CATaml mRNA; however, a slightly shorter polypeptide, =23.5 kDa, is present in much smaller amounts (lane 3). The 23.5-kDa polypeptide is also a translation product of CAT mRNA (lane 2) but is not seen clearly due to its closeness to the major 24-kDa polypeptide band. The 23.5-kDa polypeptide is related to CAT, since it is absent from a translation reaction to which no mRNA was added (lane 1) and it is immunoprecipitated by rabbit anti-CAT antibodies (data not shown). These results suggest that the 23.5-kDa polypeptide is derived by translation initiation from a weak secondary site which is located immediately downstream of, and in frame with, the major initiation codon AUG. The most likely site is the fifth codon, AUC, which differs from AUG in a single Ampr, ampicillin resistance. The tRNA gene in the pRSV plasmid is in opposite orientation to the CAT gene. The GlnRS gene in the pAC1 plasmid is in opposite orientation to the kanamycin resistance (Kan9 gene and to the lac promoter. from codon 5 (part C of Fig. 2 (21) . The tRNA genes and the CAT genes were cloned in a plasmid carrying the ColEl replication origin and ampicillin resistance marker and the GlnRS gene was cloned in a low-copy-number plasmid carrying the ACYC replication origin and kanamycin-resistance marker (Fig. 3) . The tRNA genes used were either the wild-type tRNAfMet gene trnfM (22) or the mutant trnJMT35A36 (11) .
The CAT genes used were either CAT2.5 or CATaml.2.5.
E. coli CA274 was transformed with either pAC1, a plasmid which carries a kanamycin resistance marker, or pACQS, which has the GlnRS gene inserted into EcoRI site of pAC1 (Fig. 3) (Fig. 4 Right) or kanamycin, ampicillin, and chloramphenicol (Fig. 4 extracts also showed increased f3-lactamase, another protein encoded by the pRSV CAT trnfM plasmid (Fig. 3) , in cells overproducing GlnRS (data not shown).
A more quantitative measure of the efficiency of initiation with UAG was obtained by comparing CAT enzyme activity (13) in extracts made from the set oftransformants containing the GlnRS plasmid. Results summarized in Table 1 show that efficiency of initiation with UAG is about 60-70% that with AUG. In addition, they show that synthesis of CAT polypeptide from the CATaml.2.5 gene requires the presence of the trnfMT35A36 gene.
DISCUSSION
We have shown that in the presence of tRNACUA , which is aminoacylated with glutamine in vitro, the amber termination codon UAG can initiate protein synthesis in vivo in E. coli. Thus, there is, a priori, no reason in E. coli for restricting the Proc. Natl. Acad. Sci. USA 87 (1990) 1589 initiator codon to AUG and the initiating amino acid to methionine. Our results suggest that the main reason for AUG being used as the universal codon for initiation lies in its ability to base-pair with the anticodon of the initiator tRNA on the P site of the ribosome. In other words, once the ribosome has bound to a certain region on the mRNA, it is mostly the tRNA on the P site which selects the codon that is to be used for initiation and not the ribosome (24, 25 Mutations in the anticodon sequence of elongator tRNAs often produce missense and nonsense suppressors which read codons different from those read by the corresponding wild-type tRNAs (26, 27) . In spite of this apparent precedent, our finding that tRNAfmueA, an anticodon sequence mutant of tRNAfmet, can initiate protein synthesis in E. coli with UAG is quite unexpected. The reason is that initiation of protein synthesis is a process that is quite distinct from the repetitive steps of elongation that follow it. The crucial steps in initiation all occur on the 30S ribosomal subunit, whereas the elongation reaction occurs on the 70S ribosome (24) . Initiation requires the participation of several special protein factors and a special tRNA, the initiator tRNA, whose properties are different in many respects from those of elongator tRNAs (1, (28) (29) (30) . It might, therefore, have been expected that the use of AUG as the codon and methionine as the amino acid for initiation was the result of a rigorous selection process during evolution which has preempted codons unrelated to AUG (see introduction) or amino acids other than methionine from participating in initiation. In fact, in a eukaryotic system, there are indications that protein synthesis may be initiated only with methionine (8) .
The strong stimulation in translation of CATaml mRNA in cell-free extracts upon addition of E. coli GlnRS suggests that initiation in vitro with UAG involving tRNAcfMueA occurs with glutamine ( Fig. 2, lanes 9-11) . However, overproduction of GlnRS did not lead to a specific increase in CAT protein synthesis in vivo (Fig. 5) . There are two possible explanations for this result: (i) The levels of GlnRS and the amounts of tRNAfmet produced from the multicopy pRSV plasmid (Fig.   3 ) in E. coli CA274 are such that aminoacylation of tRNACUNA with glutamine is not a limiting step for its participation in initiation of protein synthesis. (ii) Initiation in vivo involving tRNAfmet does not use glutamine. We favor the first possibility, since we showed previously that a mutant tRNA~et which carries the same anticodon sequence change as tRNAfJAe, but has additional changes which make it a poorer substrate for GlnRS than tRNAfmet, most likely inserts glutamine in vivo during suppression of amber codons (11) .
If initiation in vivo with UAG uses glutamine, it may use glutaminyl-tRNA~uejA or formylglutaminyl-tRNAf~uAf. In vitro, the Gln-tRNAfu'e1t can be formylated to fGln-tRNAfMe with Met-tRNA transformylase (B. L. Seong and U.L.R., unpublished observation), and other studies suggest that sites crucial for formylation of Met-tRNAfmet are located mostly in the acceptor stem (C. P. Lee, B. L. Seong, and U.L.R., unpublished observations). It is, therefore, likely that initiation of protein synthesis involving tRNACu'e occurs with formylglutamine. In any case, it would be interesting to see whether initiation with glutamine or formylglutamine instead offormylmethionine has any effect on the rates of turnover of the protein in E. coli (31 4 and 5 and Table 1) . Also, the level of CAT protein synthesized with UAG as the initiator codon is at least 50%, probably 60-70%, of that synthesized with AUG ( Fig. 5 and Table 1 ). Together, these findings provide an approach (i) for tightly regulated expression of genes for proteins and (ii) for overproduction in E. coli and other eubacteria of proteins which are toxic to these cells. By mutagenizing these genes such that translation of their mRNA is dependent upon the presence of tRNATueAX, expression of the protein genes may be controlled at the transcriptional or the translational level or both. In the present work, the mutant tRNAfmet gene, trnJMT35A36, is constitutively expressed; however, there are well-established systems for regulating the expression of tRNA genes in E. coli (32) . In this regard, it is also worth noting that the mutant tRNAu'eA works exclusively in initiation (11) and can, therefore, be expressed at high levels without any problems due to suppression of normal UAG termination codons. Finally, the present work represents an important step for studies on structure-function relationships of E. coli initiator tRNA. It provides an assay for in vivo function of mutant initiator tRNAs. The large number of mutants of E. coli tRNAfmet that we have generated can now each be combined with the T35A36 mutation and their ability to support synthesis of the CAT protein in vivo from the CATamJ.2.5 gene can be analyzed.
